In-depth study of the mechanism of these endogenous miRNAs in cancer therapy through the PI3K/AKT signaling pathway will help to further elucidate the complex regulatory process in vivo and provide a new theoretical basis for the subsequent targeted therapy of related diseases. This evidence concerns the gene PIK3CD and cancer.